<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2023</year>
    <pub-dates>
     <date>2023-10-09</date>
    </pub-dates>
   </dates>
   <doi>10.1007/s11172-023-3951-6</doi>
   <abstract>2-Substituted 4,5-dihydro-1H-imidazoles were synthesized by the condensation of aromatic carboxylic acids with ethylenediamine in the presence of KU-2/8 cation-exchange resin as a catalyst. Subsequent alkylation of the resulting compounds with 2-chloromethyl-gem-dichlorocyclopropane or 2-bromomethyl-1,3-dioxolane gave previously unknown substituted imidazolines containing carbo- and heterocyclic fragments. The synthesized 2-substituted 4,5-dihydro-1H-imidazoles were found to possess the antiplatelet activity at the level of acetylsalicylic acid. © 2023, Springer Science+Business Media LLC.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/2998</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/3174</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
